Loading...
Raia Drogasil S.A.
RADLY•PNK
Healthcare
Medical - Pharmaceuticals
$2.61
$-0.18(-6.45%)
Raia Drogasil S.A. (RADLY) Financial Performance & Income Statement Overview
Review Raia Drogasil S.A.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
14.40%
↑ 14.40%
Operating Income Growth
13.78%
↑ 13.78%
Net Income Growth
13.53%
↑ 13.53%
Operating Cash Flow Growth
7.13%
↑ 7.13%
Operating Margin
6.02%
↑ 6.02%
Gross Margin
28.45%
↑ 28.45%
Net Profit Margin
2.95%
↑ 2.95%
ROE
18.49%
↑ 18.49%
ROIC
18.61%
↑ 18.61%
Raia Drogasil S.A. (RADLY) Income Statement & Financial Overview
Review Raia Drogasil S.A.'s (RADLY) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $10.09B | $9.99B | $9.69B | $9.10B |
| Cost of Revenue | $7.10B | $7.02B | $6.76B | $6.44B |
| Gross Profit | $2.99B | $2.97B | $2.93B | $2.66B |
| Gross Profit Ratio | $0.30 | $0.30 | $0.30 | $0.29 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $2.46B | $2.33B | $2.27B | $2.13B |
| Operating Expenses | $2.50B | $2.29B | $2.28B | $2.13B |
| Total Costs & Expenses | $9.60B | $9.31B | $9.03B | $8.57B |
| Interest Income | -$30.03M | $9.47M | -$58.42M | -$45.66M |
| Interest Expense | $183.49M | $201.44M | $188.90M | $215.06M |
| Depreciation & Amortization | $183.43M | $464.78M | $448.27M | $436.66M |
| EBITDA | $672.49M | $1.12B | $1.06B | $902.59M |
| EBITDA Ratio | $0.07 | $0.11 | $0.11 | $0.10 |
| Operating Income | $530.53M | $724.05M | $656.44M | $526.36M |
| Operating Income Ratio | $0.05 | $0.07 | $0.07 | $0.06 |
| Other Income/Expenses (Net) | -$251.65M | -$282.96M | -$240.53M | -$246.30M |
| Income Before Tax | $278.88M | $441.09M | $415.90M | $280.05M |
| Income Before Tax Ratio | $0.03 | $0.04 | $0.04 | $0.03 |
| Income Tax Expense | -$69.23M | $101.76M | $87.23M | $86.75M |
| Net Income | $348.23M | $335.02M | $326.63M | $187.81M |
| Net Income Ratio | $0.03 | $0.03 | $0.03 | $0.02 |
| EPS | $0.21 | $0.20 | $0.19 | $0.11 |
| Diluted EPS | $0.21 | $0.20 | $0.19 | $0.11 |
| Weighted Avg Shares Outstanding | $1.71B | $1.66B | $1.72B | $1.65B |
| Weighted Avg Shares Outstanding (Diluted) | $1.71B | $1.66B | $1.72B | $1.67B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan